NOT-HL-17-567: Notice of Change of Key Dates for RFA-HL-17-015 "Bold New Bioengineering Methods and Approaches for Heart, Lung, Blood and Sleep Disorders and Diseases (R21)"

Notice of Change of Key Dates for RFA-HL-17-015 "Bold New Bioengineering Methods and Approaches for Heart, Lung, Blood and Sleep Disorders and Diseases (R21)"

Notice Number: NOT-HL-17-567

Key Dates
Release Date: December 6, 2017

Related Announcements

RFA-HL-17-015
NOT-HL-17-511

Issued by
National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice is to inform potential applicants of changes to Key Dates for RFA-HL-17-015 "Bold New Bioengineering Methods and Approaches for Heart, Lung, Blood and Sleep Disorders and Diseases (R21)". NHLBI will not accept applications for the January 10, 2019 or the May 10, 2019 receipt dates.

Part 1. Key Dates

Currently reads:

Posted Date	June 13, 2016
Open Date (Earliest Submission Date)	September 13, 2016
Letter of Intent Due Date(s)	30 days before the application due date
Application Due Date(s)	October 13, 2016; January 10, 2017; May 10, 2017; January 10, 2018; May 10, 2018; January 10, 2019; May 10, 2019 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
AIDS Application Due Date(s)	Standard AIDS dates apply, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Scientific Merit Review	March 2017, August 2017, November 2017, March 2018, August 2018, November 2018, March 2019, August 2019, November 2019
Advisory Council Review	May 2017, October 2017, January 2018, May 2018, October 2018, January 2019, May 2019, October 2019, January 2020
Earliest Start Date	July 2017, December 2017, March 2018, July 2018, December 2018, March 2019, July 2019, December 2019, March 2020
Expiration Date	May 11, 2019

Modified to read:

Posted Date	June 13, 2016
Open Date (Earliest Submission Date)	September 13, 2016
Letter of Intent Due Date(s)	30 days before the application due date
Application Due Date(s)	October 13, 2016; January 10, 2017; May 10, 2017; January 10, 2018; May 10, 2018 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
AIDS Application Due Date(s)	Standard AIDS dates apply, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Scientific Merit Review	March 2017, August 2017, November 2017, August 2018, November 2018
Advisory Council Review	May 2017, October 2017, January 2018, October 2018, January 2019
Earliest Start Date	July 2017, December 2017, March 2018, December 2018, March 2019
Expiration Date	September 8, 2018

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Martha S. Lundberg, PhD
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0513
Email: [email protected]